Video of Newborn Baby Tested with Sickle SCAN
As shown by the video, our Sickle SCAN test was used by the Moi Teaching and Referral Hospital (Kenya’s second national referral hospital) to screen a newborn baby for Sickle Cell Disease at the patient’s bedside. And as can be seen from the video, the entire testing process was fast, simple and discomfort to the patient was minimal. The test results will help initiate the right treatment for the patient, thereby significantly minimizing the risk for severe complications.
BioMedomics is committed to bring affordable, and easy-to-use diagnostic tests to the vast number of newborns affected by Sickle Cell Disease in low resource areas, where the lack of early detection has led to 50%-90% mortality rates for newborns with Sickle Cell Disease despite the availability of inexpensive lifesaving treatments.
Sickle SCAN® is a multiplexed qualitative point-of-care immunoassay used for the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell samples. The test can be completed in under 5 minutes giving real time results. It uses a small amount of whole blood from a fingerstick, heelstick, or venipuncture. To learn more about Sickle SCAN, please click here.
This test was a part of the screening program spearheaded by AMPATH-Kenya, a joint effort between the Moi University of Medicine, Moi Teaching and Referral Hospital and a consortium of US medical schools led by Indiana University. To learn more about AMPATH-Kenya, please click here.